CABRINI, Giulio
 Distribuzione geografica
Continente #
EU - Europa 4.407
NA - Nord America 1.946
AS - Asia 1.261
SA - Sud America 218
AF - Africa 25
OC - Oceania 1
Totale 7.858
Nazione #
FI - Finlandia 3.759
US - Stati Uniti d'America 1.878
SG - Singapore 433
CN - Cina 286
IT - Italia 256
VN - Vietnam 182
BR - Brasile 167
HK - Hong Kong 123
DE - Germania 92
PL - Polonia 58
GB - Regno Unito 48
JP - Giappone 43
TR - Turchia 42
ID - Indonesia 40
SE - Svezia 39
CA - Canada 37
FR - Francia 35
RU - Federazione Russa 29
UA - Ucraina 29
BD - Bangladesh 28
IN - India 25
MX - Messico 24
NL - Olanda 22
AR - Argentina 19
IQ - Iraq 15
UZ - Uzbekistan 10
ZA - Sudafrica 9
CO - Colombia 8
ES - Italia 8
PH - Filippine 7
VE - Venezuela 6
BE - Belgio 5
EC - Ecuador 5
PK - Pakistan 5
SA - Arabia Saudita 5
CL - Cile 4
MA - Marocco 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
JO - Giordania 3
LT - Lituania 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
AT - Austria 2
DZ - Algeria 2
EG - Egitto 2
IR - Iran 2
KR - Corea 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MG - Madagascar 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.858
Città #
Helsinki 3.735
Singapore 293
Ashburn 286
San Jose 173
Fairfield 126
Hong Kong 122
Beijing 116
Woodbridge 110
Ferrara 102
Santa Clara 101
Los Angeles 79
Chandler 73
Houston 67
Ho Chi Minh City 61
Dallas 59
Warsaw 56
Wilmington 48
Cambridge 46
Seattle 45
Munich 44
Tokyo 43
Hanoi 36
Jakarta 35
Ann Arbor 32
Jacksonville 30
New York 30
Shanghai 25
Lauterbourg 23
Council Bluffs 22
São Paulo 22
Buffalo 19
Izmir 19
Addison 18
Milan 17
Princeton 17
Turku 17
Atlanta 15
Brooklyn 15
Mexico City 13
Toronto 13
Chicago 12
London 11
Nanjing 11
Washington 11
Bologna 10
Denver 10
Frankfurt am Main 10
Montreal 10
Boardman 9
Chennai 9
Orem 9
Tashkent 9
Ankara 8
Bremen 8
Poplar 8
Rio de Janeiro 8
Shenyang 8
Dong Ket 7
Stockholm 7
Da Nang 6
Moscow 6
Nuremberg 6
Padova 6
Querétaro 6
San Diego 6
San Francisco 6
The Dalles 6
Tianjin 6
Amsterdam 5
Baghdad 5
Biên Hòa 5
Haiphong 5
Hebei 5
Hefei 5
Mountain View 5
Phoenix 5
Assago 4
Boston 4
Brasília 4
Changsha 4
Dearborn 4
Dhaka 4
Ferrara di Monte Baldo 4
Jiaxing 4
Johannesburg 4
Manchester 4
Nanchang 4
Naples 4
Venice 4
Vũng Tàu 4
Bogotá 3
Brussels 3
Burlingame 3
Bắc Ninh 3
Bến Tre 3
Campinas 3
Can Tho 3
Cape Town 3
Cesena 3
Charlotte 3
Totale 6.558
Nome #
A new method for measuring local ATP release at the extracellular surface of live intact cells 2.080
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.017
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 274
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 247
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 238
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 236
Anti-inflammatory activity of novel 4,6,4’-trimethylangelicin’s analogues: effects on the NF-kB activity and IL-8 expression in Cystic Fibrosis IB3-1 cells 232
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 229
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 188
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 176
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 172
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 171
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib 170
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 157
Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis 150
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 145
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 137
Mitochondrial Ca2+-dependent inflammasome activation exacerbates the P. aeruginosa-driven inflammatory response 137
miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases 123
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 114
CFTR Modulators and Reduction of Airway Inflammation in Cystic Fibrosis: How Much is Enough? 99
Overview of CF lung pathophysiology 93
Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis 85
Revealing the microRNA-transcription factors network in cystic fibrosis:from microRNA therapeutics to precision medicine (CF-miRNA-THER) FFC 7/2018 80
Evaluation of hyaluronic acid derivates as new anti-inflammatory treatments for cystic fibrosis 56
Hyaluronic acid derivates as new potential anti-inflammatory agents for Cystic Fibrosis lung disease 54
GY971, a new anti-inflammatory agent for the treatment of Cystic Fibrosis lung disease 51
Pre-clinical validation of GY971, a new anti-inflammatory agent targeting Nuclear Factor kappa B (NF-kB) 31
Totale 7.942
Categoria #
all - tutte 24.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022191 9 8 18 6 9 8 21 13 13 12 25 49
2022/2023191 21 34 4 19 22 14 25 10 16 1 14 11
2023/2024260 13 20 16 3 64 45 9 21 4 3 6 56
2024/2025731 23 29 74 52 75 52 26 39 96 62 102 101
2025/20265.764 204 67 150 208 300 183 284 114 3.926 217 82 29
Totale 7.942